The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Miners, Drug Makers And VW Drive FTSE 100 Lower

Tue, 22nd Sep 2015 11:17

LONDON (Alliance News) - UK shares were lower Tuesday midday, with commodity-related and pharmaceutical stocks the leading blue-chip fallers.

Only one FTSE 100 stock was in the green Tuesday, RSA Insurance, rebounding 1.5% after having lost 21% on Monday after Zurich Insurance pulled out of takeover talks.

The FTSE 100 was down 1.9% at 5,994,67, trading below the 6,000 line for the first time in nearly a month. The FTSE 250 index was off 1.5% at 16,640.03, and the AIM All-Share was down 0.9% at 732.97. In Europe, the CAC 40 index in Paris was down 3.0% and the DAX 30 in Frankfurt was declining 2.7%.

Stocks in Asia closed higher, with the Hang Seng index up 0.2% and the Shanghai Composite up 0.9%. The Japanese market remains closed for holiday until Thursday.

Wall Street was called for a negative open, as analysts expect global growth concerns and uncertainty over US interest rates to continue to weigh on investor confidence. US stock futures were pointed down, with the Dow 30 index seen down 1.5%, the S&P 500 off 1.6% and the Nasdaq 100 called down 1.9%.

Ahead in the US economic calendar, there is the US Redbook index at 1355 BST just before the housing price index at 1400 BST.

Oanda analyst Craig Erlam said that the absence of economic data isn't helping to lift risk appetite in the market, "with investors needing some form of positive catalyst to lift the mood".

"Ordinarily, the prospect of US interest rates staying lower for longer could have prompted such a positive response, but such is the environment we currently find ourselves in, investors instead focused on the downbeat growth and inflation forecasts and emerging markets risks," Erlam said.

In London, miners were amongst the worst performers in the blue-chip index after downgrades from Credit Suisse and lower commodity prices.

Antofagasta was down 7.1% after the bank cut it to Underperform from Neutral, while Anglo American was down 6.8% after being cut to Neutral from Outperform. Others such as Glencore, down 8.8%, BHP Billiton, down 4.5%, and Rio Tinto, down 4.1%, also were among the biggest fallers.

Head of Research at Accendo Markets Mike van Dulken said that the strength of the dollar following Thursday's US Federal Reserve decision to keep US interest rates on hold was hurting the price of commodities. As a result, gold prices retreated Tuesday to USD1,130.50, while silver also was taking a step back to USD14.98.

Other commodities such as oil were being sold as well. Brent oil prices were down at USD48.10 a barrel, coming off the level of USD50.31 prior to the Fed decision, while West Texas Intermediate was at USD45.93 a barrel, having traded at USD47.68 before the Fed announcement.

Consequently, oil-related stocks also were in the red, with BP down 2.8%, Royal Dutch Shell 'B' share down 2.6% and BG Group down 2.4%.

The pound was lower against the dollar Tuesday, standing at USD1.5442, having traded at USD1.5558 before the Fed decision on Thursday.

Pharmaceutical companies were out of favour, with Shire down 4.0%, AstraZeneca down 3.5% and GlaxoSmithKline down 3.0%, after US presidential candidate Hillary Clinton tweeted about "price gouging" in the specialty drug market.

On her official twitter account Monday, Clinton cited a New York Times article which said the price of the Daraprim drug, which treats a life-threatening parasitic infection, soared to USD750 a tablet from USD13.50 a tablet overnight.

Clinton, the frontrunner for the Democratic nomination, tweeted "price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on".

Meanwhile, analysts at UBS suggested that GKN, down 5.1%, could be retreating as shares in Volkswagen crashed again on Tuesday amid an emissions cheating scandal. Volkswagen is GKN's largest customer in its Driveline business.

The German carmaker issued a third-quarter profit warning and admitted that emissions tests for about 11 million cars around the world may have been manipulated. Europe's biggest carmaker said it is setting aside EUR6.5 billion to cover costs of the investigation into how software was used to cheat emissions tests.

Meanwhile, J Sainsbury, down 0.4%, jumped briefly into the green before giving back its gains, after Kantar Worldpanel's grocery market survey said that it was the only big four UK supermarket to increase sales in the past 12 weeks, for the second consecutive period.

Sainsbury's sales rose 0.9% in the 12 weeks to September 13 to GBP4.01 billion from GBP3.97 billion in the same period a year earlier, as its market share stayed flat at 16.2%.

Shares were down among Sainburys' blue-chip peers, whose sales Kantar said were lower, with Wm Morrison Supermarkets down 1.6% and Tesco off 1.4%.

In the FTSE 250, IG Group Holdings was the best performer, up 2.7% after it said its revenue increased substantially in the first quarter against a weak comparative, but said the volatile market conditions make it difficult to predict an outcome for the full year.

The spread betting and contracts-for-difference company, which gives retail traders access to financial markets, said it is trading in line with its expectations at present, with revenue in the first quarter to the end of August up 24% to GBP106.0 million, though it noted the same period last year was "particularly subdued".

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.